Clear cell renal cell carcinoma (ccRCC) is the most prevalent histological subtype of kidney
cancer, which is prone to metastasis, recurrence, and resistance to radiotherapy and …

Clear cell renal cell carcinoma (ccRCC) is the most common type of kidney cancer, affecting
hundreds of thousands of people worldwide and can affect people of any age. The …

T cell–based immunotherapies are a promising therapeutic approach for multiple
malignancies, but their efficacy is limited by tumor hypoxia arising from dysfunctional blood …

Disadvantages of systemically administered immunomodulatory anti-tumor therapies
include poor efficacy and high toxicity. Direct intratumoral injection of a drug is often …

Simple Summary Similarly to other solid malignancies, there is a growing interest in testing
immune checkpoint inhibitors (ICIs) for thymic epithelial tumors (TETs). However, the thymus …

Renal cell carcinoma is the most common type of kidney cancer, representing 90% of kidney
cancer diagnoses, and the deadliest urological cancer. While the incidence and mortality …

Bladder cancer is a common disease in men and the elderly. Current treatment paradigms
include radical resection of the bladder and lymph nodes or transurethral resection, both …

Introduction Complement C5a is an important component of the innate immune system. An
increasing number of reports have revealed the relevance of C5a in tumor progression; …

Over the last decade, there have been substantial progress in the field of systemic therapy
for advanced renal cell carcinoma. Through the transition from treatment with cytokines to …

Renal cell carcinoma (RCC) is a frequent urological malignancy characterized by a high rate
of metastasis and lethality. The treatment strategy for advanced RCC has moved through …